Milestone Pharmaceuticals (MIST) Current Leases (2019 - 2026)

Milestone Pharmaceuticals (MIST) has reported Current Leases for 8 consecutive years, with $670000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Leases rose 30.1% year-over-year to $670000.0; the trailing twelve-month figure through Jun 2026 stood at $670000.0 (up 30.1% YoY), and the FY2025 full-year result was $647000.0, up 13.31% from the prior year.
• Current Leases climbed to $670000.0 in Q2 2026 per MIST's latest filing, from $659000.0 in the prior quarter.
• Across five years, Current Leases topped out at $670000.0 in Q2 2026 and bottomed at $169000.0 in Q2 2022.
• Historically, Current Leases has averaged $513611.1 across 5 years, with a median of $536000.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Current Leases sank 34.75% in 2022, then jumped 208.88% in 2023.
• Over 5 years, Current Leases stood at $495000.0 in 2022, then grew by 10.3% to $546000.0 in 2023, then grew by 4.58% to $571000.0 in 2024, then grew by 13.31% to $647000.0 in 2025, then gained by 3.55% to $670000.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $670000.0, $659000.0, and $647000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.